Delivery Order SPE2DB22D1017-SPE2DB24FF7RJ
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with a firm fixed price and a ceiling value of $1,504.04. The contract has an ultimate completion date of May 19, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,193.94 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with a period of performance through March 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORILISSA 150 MG TABLET 7S, a medication, with a ceiling value of $12,606.64 and a performance period through June 6, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,618.67, is for the supply of ORILISSA 150 MG TABLET 7S pharmaceutical products. The contract has a fixed-price pricing type and a completion date of December 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,756.28 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,540.99, is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of November 3, 2023 and is a firm fixed-price delivery order. The contract is not designated with a set-aside requirement,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $11,595.78, is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, valued at $4,806.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. Amerisourcebergen Drug Corp, the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,718.59 firm-fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has a period of performance through November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4560879451 ORILISSA 150 MG TABLET 7S. The contract has a firm fixed price of $4,313.27 and an ultimate completion date of May 10, 2023. The award is not associated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF7RJDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,253.83, is for the supply of ORILISSA 150 MG TABLET 7S medication to support military and federal healthcare programs. The contract is a firm fixed-price delivery order with a completion date of May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 5/14/24 |